Consumption of a defined, plant-based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeks

Clinical Cardiology
Rami S NajjarBaxter D Montgomery

Abstract

Lipoprotein(a) [Lp(a)] is a highly atherogenic lipoprotein and is minimally effected by lifestyle changes. While some drugs can reduce Lp(a), diet has not consistently shown definitive reduction of this biomarker. The effect of consuming a plant-based diet on serum Lp(a) concentrations have not been previously evaluated. Consumption of a defined, plant-based for 4 weeks reduces Lp(a). Secondary analysis of a previous trial was conducted, in which overweight and obese individuals (n = 31) with low-density lipoprotein cholesterol concentrations >100 mg/dL consumed a defined, plant-based diet for 4 weeks. Baseline and 4-week labs were collected. Data were analyzed using a paired samples t-test. Significant reductions were observed for serum Lp(a) (-32.0 ± 52.3 nmol/L, P = 0.003), apolipoprotein B (-13.2 ± 18.3 mg/dL, P < 0.0005), low-density lipoprotein (LDL) particles (-304.8 ± 363.0 nmol/L, P < 0.0005) and small-dense LDL cholesterol (-10.0 ± 9.2 mg/dL, P < 0.0005). Additionally, serum interleukin-6 (IL-6), total white blood cells, lipoprotein-associated phospholipase A2 (Lp-PLA2), high-sensitivity c-reactive protein (hs-CRP), and fibrinogen were significantly reduced (P ≤ 0.004). A defined, plant-based diet has a favorable impa...Continue Reading

References

Jul 1, 1992·The Journal of Clinical Investigation·E BoerwinkleH H Hobbs
May 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J R GuytonA M Gotto
Oct 7, 1988·JAMA : the Journal of the American Medical Association·M A AustinR M Krauss
Feb 1, 1996·European Journal of Clinical Investigation·S FrankG M Kostner
Dec 31, 1997·The Journal of Clinical Investigation·K M ArgravesD K Strickland
Apr 5, 2001·Metabolism: Clinical and Experimental·D J JenkinsP W Connelly
Jan 24, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Marja-Leena SilasteSohvi Hörkkö
Jul 3, 2008·Journal of Lipid Research·Claes BergmarkSotirios Tsimikas
Jul 23, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Dec 25, 2009·The New England Journal of Medicine·Robert ClarkeUNKNOWN PROCARDIS Consortium
Aug 18, 2010·Journal of Lipid Research·Nastaran FaghihniaRonald M Krauss
Oct 23, 2010·European Heart Journal·Børge G NordestgaardUNKNOWN European Atherosclerosis Society Consensus Panel
Mar 10, 2012·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Oana VittosElena Moldoveanu
Sep 20, 2012·Cholesterol·Kirsten Riches, Karen E Porter
Oct 5, 2012·The New England Journal of Medicine·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Jan 11, 2013·International Journal of Rheumatology·I MissalaE Steinhagen-Thiessen
Dec 8, 2015·Journal of Lipid Research·Julian C van CapelleveenErik S G Stroes
Feb 9, 2016·Critical Reviews in Food Science and Nutrition·Monica DinuFrancesco Sofi
Jul 14, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·F EichelmannK Aleksandrova
Oct 28, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Steve VarvelSotirios Tsimikas

❮ Previous
Next ❯

Citations

Dec 26, 2019·International Heart Journal·Yingzhi ChongYong Zhou
May 5, 2020·International Journal of Food Sciences and Nutrition·Spyridon N KarrasKalliopi Kotsa
Jun 28, 2019·Frontiers in Nutrition·Kathleen E AllenRobert J Ostfeld
Jun 7, 2020·Nutrients·Aleksandra Sidor, Piotr Rzymski
Oct 11, 2020·Current Cardiology Reports·Brian ClarkKim Williams
Jul 17, 2019·Clinical Therapeutics·Heitor O SantosRodrigo C O Macedo
Feb 11, 2021·International Journal of Molecular Sciences·Rami S Najjar, Rafaela G Feresin
Feb 4, 2021·Current Opinion in Endocrinology, Diabetes, and Obesity·Don P WilsonPatrick M Moriarty
Apr 28, 2020·The American Journal of Cardiology·Nishant P ShahManesh R Patel
Apr 9, 2021·The Journal of Nutrition·Jeenan KaiserClare Oliver-Williams
May 1, 2021·International Journal of Environmental Research and Public Health·Shila Minari HargreavesRenata Puppin Zandonadi
Aug 7, 2021·Biomedicines·Gabriella IannuzzoMarco Gentile
Mar 30, 2019·Journal of the American College of Cardiology·Ron BlanksteinDeepak L Bhatt

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.